MAP4K3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.409000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.215200E-01
Normal-vs-Stage2
5.907000E-01
Normal-vs-Stage3
4.894800E-01
Normal-vs-Stage4
7.732500E-02
Stage1-vs-Stage2
8.078400E-01
Stage1-vs-Stage3
1.576610E-01
Stage1-vs-Stage4
4.632200E-02
Stage2-vs-Stage3
1.836970E-01
Stage2-vs-Stage4
1.245610E-01
Stage3-vs-Stage4
1.588350E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.571000E-01
Normal-vs-AfricanAmerican
4.608400E-01
Normal-vs-Asian
7.755200E-01
Caucasian-vs-AfricanAmerican
4.650200E-01
Caucasian-vs-Asian
8.053800E-01
AfricanAmerican-vs-Asian
3.516800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.273600E-01
Normal-vs-Female
6.527000E-01
Male-vs-Female
6.495400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.798000E-01
Normal-vs-Age(41-60Yrs)
3.705600E-01
Normal-vs-Age(61-80Yrs)
7.547000E-01
Normal-vs-Age(81-100Yrs)
8.461800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.172400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.262200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.774200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.231600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.476000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.557200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.552800E-01
Normal-vs-Daily Drinker
7.870200E-01
Normal-vs-Weekly Drinker
9.794400E-01
Normal-vs-Occasional Drinker
4.002000E-01
Normal-vs-Social Drinker
6.650800E-01
Non Drinker-vs-Daily Drinker
8.284000E-01
Non Drinker-vs-Weekly Drinker
5.589800E-01
Non Drinker-vs-Occasional Drinker
2.122400E-01
Non Drinker-vs-Social Drinker
6.165600E-01
Daily Drinker-vs-Weekly Drinker
5.782600E-01
Daily Drinker-vs-Occasional Drinker
5.168200E-01
Daily Drinker-vs-Social Drinker
8.609400E-01
Weekly Drinker-vs-Occasional Drinker
1.617600E-01
Weekly Drinker-vs-Social Drinker
4.348000E-01
Occasional Drinker-vs-Social Drinker
6.285800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.571500E-02
Normal-vs-Grade 2
4.278400E-03
Normal-vs-Grade 3
8.596700E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.237600E-02
Grade 1-vs-Grade 3
2.877700E-02
Grade 1-vs-Grade 4
7.571500E-02
Grade 2-vs-Grade 3
6.522200E-01
Grade 2-vs-Grade 4
4.278400E-03
Grade 3-vs-Grade 4
8.596700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.205200E-01
Normal-vs-NonDiabetic
6.454400E-01
Diabetic-vs-NonDiabetic
3.023200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.193800E-01
Normal-vs-NoPancreatitis
7.213600E-01
Pancreatitis-vs-NoPancreatitis
6.040400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.097400E-01
Normal-vs-N1
6.045400E-01
N0-vs-N1
6.218400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.734600E-01
Normal-vs-TP53-NonMutant
7.583200E-01
TP53-Mutant-vs-TP53-NonMutant
1.917950E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
